While Chewy and its Autoship feature for customers ordering pet food, treats, or medicine is about as "pick-and-shovel" as it gets, there is a hidden gem that may be the ultimate pick-and-shovel pet stock: Idexx Laboratories (NASDAQ: IDXX). Idexx Labs is a leading provider of a wide array of point-of-care platforms, diagnostic tests, and Software-as-a-Service offerings for the animal health industry, helping veterinarians care for our furry friends. The stock has delivered total returns of 20% annually si ...

Analysts on Wall Street project that Elanco Animal Health Incorporated (ELAN) will announce quarterly earnings of $0.11 per share in its forthcoming report, representing a decline of 21.4% year over year. Revenues are projected to reach $1.09 billion, increasing 7.1% from the same quarter last year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Prior ...

Key Takeaways Cencora will merge MWI with Covetrus in a deal valuing MWI at a $3.5 billion enterprise value.COR will receive $1.25B cash, $800M preferred equity and $1.45B common equity, keeping a 34.3% stake.The combined platform will integrate MWI's supply chain with Covetrus' tech to boost efficiency and growth.Cencora, Inc. (COR) recently announced that it has agreed to merge its wholly owned subsidiary, MWI Animal Health, with Covetrus in a transaction that values MWI at an enterprise value of $3.5 bil ...

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America 2026 Virtual Animal Health Summit. Chief Financial Officer, Glenn David; Chief Operating Officer, Larry Miller and Executive Vice President, Corporate Strategy and CEO designate Daniel Bendheim will address financial analysts and investors on Thursday, February 26, 2026, at 10:45 AM ET. The live audio presentation will be available on the Phibro Animal Healt. ...

Core Viewpoint - ImmuCell Corporation is set to report its unaudited financial results for the quarter and year ended December 31, 2025, on March 4, 2026, with a conference call scheduled for the following morning to discuss these results [1][2][3]. Financial Reporting - The company anticipates no changes to the preliminary sales results disclosed on January 8, 2026, for the quarter and year ended December 31, 2025 [3]. - ImmuCell plans to file its Annual Report on Form 10-K on or before March 31, 2026 [3]. Company Overview - ImmuCell Corporation focuses on developing, manufacturing, and marketing products that enhance cattle health and productivity, including its product First Defense, which provides Immediate Immunity™ to newborn dairy and beef calves [4].

Core Viewpoint - Phibro Animal Health Corporation (NASDAQ:PAHC) is recognized as one of the seven cheap pharmaceutical stocks to consider for investment, particularly noted for its strong operational performance and positive financial outlook [1][2]. Financial Performance - For the fiscal second quarter ending December 31, 2025, Phibro reported a 21% increase in net sales to $373.9 million and a rise in net income to $27.5 million [4]. - Adjusted EBITDA increased by 41% to $68.1 million, while adjusted diluted EPS rose by 58% to $0.87 [4]. - The company has updated its fiscal 2026 net sales estimates to between $1.45 billion and $1.50 billion, with adjusted EBITDA projected between $245 million and $255 million, reflecting improved operating momentum [5]. Analyst Ratings - Morgan Stanley raised its price target for PAHC from $45 to $49, maintaining an Equal Weight rating, citing strong operational performance and effective execution in the Animal Health segment [3]. - The upgrade was influenced by significant margin expansion, a favorable fiscal 2026 forecast, and a profit beat in the second quarter [3].

PetVivo (OTCPK:PETV) Q3 2026 Earnings call February 17, 2026 05:00 PM ET Company ParticipantsGarry Lowenthal - CFOJohn Dolan - Chief Business Development Officer and General CounselJohn Lai - CEOConference Call ParticipantsNone - AnalystJohn DolanGood afternoon, everyone. Thank you for joining us today to discuss our results for our third quarter and first nine months of fiscal 2026, ended December 31, 2025. Hosting our call today is our Chief Executive Officer, John Lai, and our Chief Financial Officer, Ga ...

PetVivo (OTCPK:PETV) Q3 2026 Earnings call February 17, 2026 05:00 PM ET Company ParticipantsGarry Lowenthal - CFOJohn Dolan - Chief Business Development Officer and General CounselJohn Lai - CEOConference Call ParticipantsNone - AnalystJohn DolanGood afternoon, everyone. Thank you for joining us today to discuss our results for our third quarter and first nine months of fiscal 2026, ended December 31, 2025. Hosting our call today is our Chief Executive Officer, John Lai, and our Chief Financial Officer, Ga ...

PetVivo (OTCPK:PETV) Q3 2026 Earnings call February 17, 2026 05:00 PM ET Speaker1Good afternoon, everyone. Thank you for joining us today to discuss our results for our third quarter and first nine months of fiscal 2026, ended December 31, 2025. Hosting our call today is our Chief Executive Officer, John Lai, and our Chief Financial Officer, Garry Lowenthal, as well as myself, John Dolan, PetVivo's Chief Business Development Officer and General Counsel. Following our remarks, we'll open the call to your que ...

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of 山東信得科技股份有限公司 Shandong Sinder Technology Co., Ltd. (A joint stock company incorporated in the People's Republic of C ...